Bioinformatic identification and clinical validation of VIM and OSM as prognostic biomarkers in cerebral infarction: implications for risk stratification.

BACKGROUND: Reliable molecular biomarkers for predicting cerebral infarction outcomes remain limited, highlighting the need for integrative approaches that bridge bioinformatic discovery with clinical validation. OBJECTIVE: To identify key differenti…

Preview only. Read the full abstract at the source